Cargando…

Incidence of SARS-CoV-2 Infection in Health Care Workers After a Single Dose of mRNA-1273 Vaccine

This cohort study of health care workers in a metropolitan Veterans Administration network examines the association of SARS-CoV-2 infection after receiving a single dose of mRNA-1273 vaccine compared with no vaccination.

Detalles Bibliográficos
Autores principales:	Gupta, Kalpana, O’Brien, William J., Bellino, Pamela, Linsenmeyer, Katherine, Doshi, Sucheta J., Sprague, Robert S., Charness, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209555/ https://www.ncbi.nlm.nih.gov/pubmed/34132795 http://dx.doi.org/10.1001/jamanetworkopen.2021.16416

Ejemplares similares

Vaccination Status and the Detection of SARS-CoV-2 Infection in Health Care Personnel Under Surveillance in Long-term Residential Facilities
por: Linsenmeyer, Katherine, et al.
Publicado: (2021)

Sickness presenteeism in healthcare workers during the coronavirus disease 2019 (COVID-19) pandemic: An observational cohort study
por: Linsenmeyer, Katherine, et al.
Publicado: (2023)

Minimal Population Prevalence and Mortality of Coronavirus Disease 2019 in Healthcare Personnel
por: Gupta, Kalpana, et al.
Publicado: (2020)

Adverse effects of nasopharyngeal swabs: Three-dimensional printed versus commercial swabs
por: Gupta, Kalpana, et al.
Publicado: (2020)

Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers
por: Hasibuan, Anshari Saifuddin, et al.
Publicado: (2023)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

C. difficile Screening for Colonization among Surgical Ward Admissions Is Feasible and Useful
por: Linsenmeyer, Katherine, et al.
Publicado: (2017)

Concordance of SARS-CoV-2 RNA in Aerosols From a Nurses Station and in Nurses and Patients During a Hospital Ward Outbreak
por: Stern, Rebecca A., et al.
Publicado: (2022)

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

489 Accuracy of Clinicians' Empiric Treatment Choices for Resistant Gram-Negative Uropathogens
por: Linsenmeyer, Katherine, et al.
Publicado: (2014)

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine
por: Tailor, Prashant D, et al.
Publicado: (2021)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

mrna-1273: Erythema nodosum: case report
Publicado: (2021)

mrna-1273: Immediate hypersensitivity: case report
Publicado: (2021)

mrna-1273: Acute myocarditis: case report
Publicado: (2021)

mRNA-1273: Myopericarditis: case report
Publicado: (2021)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
por: Huang, Szu-Ting, et al.
Publicado: (2023)

Acute Myopericarditis After First Dose of mRNA-1273 SARS-CoV-2 Vaccine in a Young Adult
por: Fadah, Kahtan, et al.
Publicado: (2022)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
por: Dong, Ning, et al.
Publicado: (2021)

Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination
por: Williams, Curtis B., et al.
Publicado: (2021)

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
por: Doria-Rose, Nicole A., et al.
Publicado: (2021)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers
por: Klingel, Hanna, et al.
Publicado: (2022)

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022)

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
por: El Sahly, Hana M., et al.
Publicado: (2021)

Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
por: Lopes de Assis, Felipe, et al.
Publicado: (2023)

Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
por: Garcia-Dominguez, Dario, et al.
Publicado: (2022)

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hh9953l70k63snsjni6uf83ggk